Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Oct 07, 2024

BUY
$4.26 - $6.84 $258,679 - $415,345
60,723 New
60,723 $283,000
Q2 2022

Aug 12, 2022

SELL
$8.35 - $21.89 $1.36 Million - $3.57 Million
-163,276 Reduced 72.89%
60,723 $635,000
Q1 2022

May 13, 2022

SELL
$16.97 - $31.93 $21.1 Million - $39.6 Million
-1,240,901 Reduced 84.71%
223,999 $4.62 Million
Q4 2021

Feb 11, 2022

BUY
$25.61 - $41.78 $35.9 Million - $58.5 Million
1,400,177 Added 2163.34%
1,464,900 $45.8 Million
Q2 2021

Aug 11, 2021

SELL
$17.48 - $25.46 $28,474 - $41,474
-1,629 Reduced 2.46%
64,723 $1.47 Million
Q1 2021

May 11, 2021

BUY
$18.08 - $28.8 $1,609 - $2,563
89 Added 0.13%
66,352 $1.52 Million
Q4 2020

Feb 09, 2021

BUY
$11.7 - $23.41 $4,598 - $9,200
393 Added 0.6%
66,263 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$11.21 - $13.82 $7,039 - $8,678
-628 Reduced 0.94%
65,870 $773,000
Q2 2020

Aug 14, 2020

SELL
$9.8 - $12.77 $1,372 - $1,787
-140 Reduced 0.21%
66,498 $758,000
Q4 2019

Feb 14, 2020

SELL
$13.12 - $17.06 $5.2 Million - $6.77 Million
-396,626 Reduced 85.62%
66,638 $1.07 Million
Q3 2019

Nov 14, 2019

SELL
$12.75 - $19.01 $13.1 Million - $19.6 Million
-1,030,461 Reduced 68.99%
463,264 $6.35 Million
Q2 2019

Aug 14, 2019

SELL
$17.0 - $21.88 $3.61 Million - $4.64 Million
-212,081 Reduced 12.43%
1,493,725 $27.5 Million
Q1 2019

May 15, 2019

BUY
$15.53 - $22.15 $10.6 Million - $15.1 Million
679,724 Added 66.24%
1,705,806 $35 Million
Q4 2018

Feb 14, 2019

BUY
$14.06 - $22.57 $503,811 - $808,750
35,833 Added 3.62%
1,026,082 $17.1 Million
Q3 2018

Nov 14, 2018

BUY
$13.35 - $19.1 $3.19 Million - $4.56 Million
239,000 Added 31.81%
990,249 $17 Million
Q2 2018

Aug 14, 2018

BUY
$10.35 - $16.45 $677,655 - $1.08 Million
65,474 Added 9.55%
751,249 $10.8 Million
Q1 2018

May 15, 2018

BUY
$8.0 - $12.8 $5.49 Million - $8.78 Million
685,775 New
685,775 $7.54 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $257M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.